La Jolla Pharmaceutical Co. Stock Price - LJPC

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 9.99 ▲ 0.09 (0.91%)
Company Name Stock Ticker Symbol Market Type ISIN Company Description
La Jolla Pharmaceutical Co. LJPC NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.19 1.96% 9.90 10.06 9.66 9.72 9.71 19:35:59
Bid Price Ask Price Spread Spread % News
9.90 10.00 0.10 1.00% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,049 524,748 $ 9.93 $ 5,210,249 855,046 5.01 - 38.39
Last Trade Time Type Quantity Stock Price Currency
17:55:52 20 $ 9.90 USD

La Jolla Pharmaceutical Co. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 268.28M 27.1M $ -199.47M -7.85 0.00 16.59M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ 0.00 0.00% 3.62k 0.00%

more financials information »

La Jolla Pharmaceutical Co. News

Latest LJPC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical LJPC Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week12.4113.889.07510.10731M4M2M-2.51-20.23%
1 Month6.0513.95.1711.1749180k24M3M3.8563.64%
3 Months6.7313.95.1710.1504176k24M1M3.1747.10%
6 Months12.7313.95.018.4746176k24M1M-2.83-22.23%
1 Year30.1538.395.0112.2218114k24M789k-20.25-67.16%
3 Years17.741.3595.0121.049638k24M510k-7.8-44.07%
5 Years8.7944.98995.0120.9704224M381k1.1112.63%

La Jolla Pharmaceutical Co. Description

La Jolla Pharmaceutical Co. is a biopharmaceutical company engaged in the discovery, development and commercialization of therapeutics for chronic organ failure and cancer. It is engaged in the drug development of two products: GCS-100 and LJPC-501.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.